Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Heiss

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Annals of Surgery|December 31, 1997
Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancerM M Heiss, H Allgayer, K U Gruetzner, et al.
Zentralblatt Fur Chirurgie|June 21, 2005
[Laparoscopic incisional hernia repair -- an alternative to the conventional procedure?]M K Angele, F Löhe, J Dietz, et al.
Cancer Research|April 1, 1997
Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor diseaseH Allgayer, M M Heiss, R Riesenberg, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 1, 1991
Evaluation of protective mAbs against Pseudomonas aeruginosa outer membrane protein I by C1q binding assayA Eckhardt, M M Heiss, W Ehret, et al.
Trials|January 18, 2019
BIOLAP: biological versus synthetic mesh in laparo-endoscopic inguinal hernia repair: study protocol for a randomized, multicenter, self-controlled clinical trialC S Seefeldt, J S Meyer, J Knievel, et al.
Surgical Endoscopy|January 13, 2023
The VACStent trial: combined treatment of esophageal leaks by covered stent and endoscopic vacuum therapyJ Lange, G Kähler, J Bernhardt, et al.
Clinical & Experimental Metastasis|March 21, 1998
Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patternsH Allgayer, R Babic, K U Grützner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator systemM M Heiss, R Babic, H Allgayer, et al.
Nature Medicine|October 1, 1995
Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancerM M Heiss, H Allgayer, K U Gruetzner, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1996
The prognostic impact of the urokinase-type plasminogen activator system is associated with tumour differentiation in gastric cancerM M Heiss, R Babic, H Allgayer, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Annals of Surgery|December 31, 1997
Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancerM M Heiss, H Allgayer, K U Gruetzner, et al.
Zentralblatt Fur Chirurgie|June 21, 2005
[Laparoscopic incisional hernia repair -- an alternative to the conventional procedure?]M K Angele, F Löhe, J Dietz, et al.
Cancer Research|April 1, 1997
Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor diseaseH Allgayer, M M Heiss, R Riesenberg, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|April 1, 1991
Evaluation of protective mAbs against Pseudomonas aeruginosa outer membrane protein I by C1q binding assayA Eckhardt, M M Heiss, W Ehret, et al.
Trials|January 18, 2019
BIOLAP: biological versus synthetic mesh in laparo-endoscopic inguinal hernia repair: study protocol for a randomized, multicenter, self-controlled clinical trialC S Seefeldt, J S Meyer, J Knievel, et al.
Surgical Endoscopy|January 13, 2023
The VACStent trial: combined treatment of esophageal leaks by covered stent and endoscopic vacuum therapyJ Lange, G Kähler, J Bernhardt, et al.
Clinical & Experimental Metastasis|March 21, 1998
Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patternsH Allgayer, R Babic, K U Grützner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator systemM M Heiss, R Babic, H Allgayer, et al.
Nature Medicine|October 1, 1995
Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancerM M Heiss, H Allgayer, K U Gruetzner, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1996
The prognostic impact of the urokinase-type plasminogen activator system is associated with tumour differentiation in gastric cancerM M Heiss, R Babic, H Allgayer, et al.
Pageof 7